Pay in 4 interest-free payments of $7.38 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Contraindications and health history: Do you have any conditions that make one drug safer than another
Country of origin : Republic of Korea
On a unit-to-unit basis, TOUJEO had a lower maximum (GIRmax) and 24-hour glucose lowering effect (GIR-AUC0-24) compared to LANTUS
Expense Ratio: 0.59% Tema GLP-1, Obesity & Cardiometabolic ETF (HRTS): Investment Objective: Tema GLP-1, Obesity & Cardiometabolic ETF (the Fund) seeks to provide long-term growth of capital
US$ 27.45
US$ 27.58
US$ 28.17
